Prime Medicine GAAP EPS of -$0.41 misses by $0.03, revenue of $1.11M misses by $1.89M
Source: SeekingAlpha
2025-08-07 08:29:52 ET
More on Prime Medicine
- Prime Medicine: Pressing Forward With Lead Liver Targeting Indications
- Prime Medicine slides after pricing $125.4M stock offering
- Prime Medicine soars as Jones sees it as an acquisition target
- Seeking Alpha’s Quant Rating on Prime Medicine
- Historical earnings data for Prime Medicine
Read the full article on Seeking Alpha
For further details see:
Prime Medicine GAAP EPS of -$0.41 misses by $0.03, revenue of $1.11M misses by $1.89M
First Trust Heitman Global Prime Real Estate ETF
NASDAQ: PRME
PRME Trading
2.89% G/L:
$3.9099 Last:
434,832 Volume:
$3.99 Open:
PRME Latest News
March 03, 2026 08:00:00 am
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
PRME Stock Data
$629,079,643
97,403,551
13.07%
59
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
